DAJY(SZ:002030)2022-12-08 09:31Group 1: Company Overview - The company is 中山大学达安基因股份有限公司, with the stock code 002030 and the abbreviation 达安基因 [1] - The investor relations activity was conducted on December 3, 2014, at the company headquarters in Guangzhou [1] Group 2: Collaboration and Product Applications - The collaboration with LIFE company is non-exclusive, allowing other companies to use its instruments [2] - The second-generation gene sequencer and related reagents are currently applied in non-invasive prenatal screening clinical applications, with ongoing research for other application areas [2] Group 3: Customer Base and Market Insights - The primary customers for the second-generation gene sequencing products are major hospitals in China [2] - Independent laboratories are emerging, with differences in operational models between domestic and international markets [3] Group 4: Future Development and Strategy - The company will decide on establishing new independent laboratories based on market conditions, with a focus on enhancing profitability [3] - The strategic goal is to become a leading integrated supplier in the diagnostic industry, with opportunities across all segments of the supply chain [3] - There are currently no plans for mergers or acquisitions, as the market space remains challenging to explore [4]